serb
PrivateLast Round
Debt
Jul 15, 2025
Est. Valuation
$756M
Total Funding Raised
$0
Company Overview
A specialty pharmaceutical group focused on prescription medicines for rare and life-threatening diseases.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
serb Comparables
Compare serb with similar companies based on industry and business-model similarity.
serb Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 15, 2025 | ||||
| Private Equity | Jun 8, 2023 | ||||
| Private Equity | Feb 28, 2021 | ||||
| Buyout/LBO | Jun 9, 2017 |
serb Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about serb's valuation, stock price, and market status.